Audion Therapeutics

Audion Therapeutics BV is a biopharmaceutical company dedicated to the discovery, development, and commercialization of drugs and delivery technologies for the treatment of diseases affecting the ear, including hearing loss. The company's small molecule drug discovery program for hearing loss focuses on inner hair cell regeneration. Its intellectual property portfolio includes new molecules, delivery systems, and drug discovery tools for hearing and hearing loss research. The company was founded in 2008 and is headquartered in Amsterdam, the Netherlands.